Cargando…
Clostridioides difficile infection in the critically ill: what kind of therapy for refractory cases
Autores principales: | Honore, Patrick M., Mugisha, Aude, Kugener, Luc, Redant, Sebastien, Attou, Rachid, Gallerani, Andrea, De Bels, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7146904/ https://www.ncbi.nlm.nih.gov/pubmed/32272951 http://dx.doi.org/10.1186/s13054-020-02869-8 |
Ejemplares similares
-
Acyclovir for ventilator-associated pneumonia refractory to antibiotics and with high viral herpes simplex load: we are not sure
por: Honore, Patrick M., et al.
Publicado: (2020) -
Treatment of influenza virus-related critical illness during continuous renal replacement therapy: take caution with dosing
por: Honore, Patrick M., et al.
Publicado: (2020) -
High doses of ketamine to improve neuronal edema in subarachnoid hemorrhage: we should consider other undesirable organ targets
por: Honore, Patrick M., et al.
Publicado: (2020) -
With the current COVID pandemic: should we use single-use flexible bronchoscopes instead of conventional bronchoscopes?
por: Honore, Patrick M., et al.
Publicado: (2020) -
The use of a neuromuscular blocking agent could significantly decrease mortality in moderate-to-severe ARDS patients: is moderate ARDS the best indication for neuromuscular blocking agents
por: Honore, Patrick M., et al.
Publicado: (2020)